An Evaluation of LY007 Cell Injection for r/r B-NHL
Clinical trial NCT06279611 · UNKNOWN
Trial details
- NCT number
- NCT06279611
- Sponsor
- Shanghai Longyao Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-25
- Primary completion
- 2024-08-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.